BNP Paribas Financial Markets Invests $50,000 in Astria Therapeutics, Inc. (NASDAQ:ATXS)
BNP Paribas Financial Markets bought a new position in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 5,572 shares of the biotechnology company’s stock, valued at approximately $50,000. Other institutional investors also recently modified their holdings of the company. Rhumbline Advisers lifted its […]
BNP Paribas Financial Markets bought a new position in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 5,572 shares of the biotechnology company’s stock, valued at approximately $50,000. Other institutional investors also recently modified their holdings of the company. Rhumbline Advisers lifted its […]
